Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cisplatin nephrotoxicity: a review.

Xin Yao1, Kessarin Panichpisal, Neil Kurtzman

  • 1Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas 79430, USA.

The American Journal of the Medical Sciences
|August 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Underutilization of Osteoporosis Screening in Patients With Severe COPD and Long Term Corticosteroid Use.

Journal of primary care & community health·2026
Same author

Renal Venous Hypertension and Kidney Dysfunction: Implications for Clinical Practice.

Cardiology in review·2026
Same author

Ruptured Brain Arteriovenous Malformation Coexisting With Reversible Cerebral Vasoconstriction Syndrome: A Case Report.

Cureus·2026
Same author

Sotatercept for pulmonary arterial hypertension on background therapy: a systematic review and meta-analysis of randomized controlled trials.

Proceedings (Baylor University. Medical Center)·2026
Same author

My Patient Has Episodic Dyspnea: Should I Order Spirometry With Bronchodilators?

Chest·2025
Same author

Commentary on manuscript entitled "Association of vasoactive active-inotropic score and poor outcomes in patients who underwent coronary artery bypass grafting: Systematic review and meta-analysis" in press <i>Perfusion</i>.

Perfusion·2025

Cisplatin, a key cancer drug, can harm kidneys. Understanding its toxic mechanisms helps in developing new ways to prevent or treat this cisplatin nephrotoxicity.

Area of Science:

  • Nephrology
  • Oncology
  • Pharmacology

Background:

  • Cisplatin is a vital chemotherapy agent for solid tumors.
  • A significant side effect is dose-dependent kidney damage (nephrotoxicity).

Purpose of the Study:

  • To review current literature on cisplatin-induced kidney injury.
  • To identify mechanisms of damage and potential preventive/therapeutic strategies.

Main Methods:

  • Comprehensive review of clinical and experimental studies.
  • Analysis of literature on cisplatin nephrotoxicity.

Main Results:

  • Cisplatin enters renal tubular cells via transport.
  • It causes cytotoxicity, inflammation, and fibrogenesis, leading to tubular damage and dysfunction.

Related Experiment Videos

  • Volume expansion and saline diuresis are effective preventive measures.

    • Conclusions:

    • Knowledge of injury mechanisms informs prevention strategies.
    • Findings may apply to other nephrotoxic drugs.